Serotonergic denervation does not reduce brain uptake of n-isopropyl-p-[123I]iodoamphetamine in vivo

B M de Jong, J M Ruijter, T P Van der Woude, M Mirmiran, E A van Royen

Research output: Contribution to journalArticleAcademicpeer-review

1 Citation (Scopus)

Abstract

The relation between brain uptake of radiolabeled n-isopropyl-p-iodoamphetamine [( 123I]IMP) and serotonin re-uptake sites was studied in vivo by lesioning serotonergic nerve endings. The reduction of brain serotonin demonstrated the effectiveness of the procedure. Accumulation of radioactivity/g brain tissue was higher in the lesioned than in the sham-operated rats. This was explained by the loss of body weight of the lesioned animals, allowing an increased distribution to the brain. These results demonstrate that the in vivo distribution and binding of [123I]IMP in the brain is not limited to the specific serotonin re-uptake sites on nerve endings.

Original languageEnglish
Pages (from-to)753-757
Number of pages5
JournalNuclear Medicine and Biology
Volume16
Issue number8
DOIs
Publication statusPublished - 1989
Externally publishedYes

Keywords

  • Amphetamines
  • Animals
  • Brain
  • Iodine Radioisotopes
  • Iofetamine
  • Male
  • Rats
  • Rats, Inbred Strains
  • Receptors, Serotonin

Fingerprint

Dive into the research topics of 'Serotonergic denervation does not reduce brain uptake of n-isopropyl-p-[123I]iodoamphetamine in vivo'. Together they form a unique fingerprint.

Cite this